Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The proteins ceruloplasmin (p < 0.001 and p < 0.001), inter alpha trypsin inhibitor heavy chain H4 (p = 0.019 and p = 0.021), apolipoprotein E (p = 0.0087 and p = 0.0147), vitamin D binding protein (p = 0.0208 and p = 0.0237) and kininogen-1 (p = 0.0007 and p = 0.0163) showed statistically significant differences in both peptides after statistical analysis using a Student t-test (p < 0.05) (Figure 6A).

Source: NSTEACS patients vs healthy controls. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

For the validation process, independent groups of samples from healthy controls and NSTEACS or STEACS patients were used.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome

Study design awaiting verification · Proteome Science · 2014

Original publication title

The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome

Carlos M Laborde; Sergio Alonso-Orgaz; Laura Mourino-Alvarez; José Moreu; Fernando Vivanco; Luis R Padial; María G Barderas

© Laborde et al.; licensee BioMed Central Ltd. 2014

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

We purpose the severity of hypoxia as the cornerstone for explaining the differences observed between both groups.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Acute coronary syndrome is the major cause of death in developed countries. Despite its high prevalence, there is still a strong need for new biomarkers which permit faster and more accurate diagnostics and new therapeutic drugs. The basis for this challenge lay in improving our understanding of the whole atherosclerotic process from atherogenesis to atherothrombosis. In this study, we conducted two different proteomic analyses of peripheral blood plasma from non-ST elevation acute coronary syndrome and ST elevation acute coronary syndrome patients vs healthy controls.

Source: Background

Abstract: Results

Two-dimensional Fluorescence Difference in Gel Electrophoresis and mass spectrometry permitted the identification of 31 proteins with statistical differences (p < 0.05) between experimental groups. Additionally, validation by Western blot and Selected Reaction Monitoring permitted us to confirm the identification of a different and characteristic plasma proteomic signature for NSTEACS and STEACS patients.

Source: Results

Abstract: Conclusions

We purpose the severity of hypoxia as the cornerstone for explaining the differences observed between both groups.

Source: Conclusions
Authors’ abstract

Background

Acute coronary syndrome is the major cause of death in developed countries. Despite its high prevalence, there is still a strong need for new biomarkers which permit faster and more accurate diagnostics and new therapeutic drugs. The basis for this challenge lay in improving our understanding of the whole atherosclerotic process from atherogenesis to atherothrombosis. In this study, we conducted two different proteomic analyses of peripheral blood plasma from non-ST elevation acute coronary syndrome and ST elevation acute coronary syndrome patients vs healthy controls.

Results

Two-dimensional Fluorescence Difference in Gel Electrophoresis and mass spectrometry permitted the identification of 31 proteins with statistical differences (p < 0.05) between experimental groups. Additionally, validation by Western blot and Selected Reaction Monitoring permitted us to confirm the identification of a different and characteristic plasma proteomic signature for NSTEACS and STEACS patients.

Conclusions

We purpose the severity of hypoxia as the cornerstone for explaining the differences observed between both groups.

Publication and source details

Original title: The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome

Carlos M Laborde; Sergio Alonso-Orgaz; Laura Mourino-Alvarez; José Moreu; Fernando Vivanco; Luis R Padial; María G Barderas

Proteome Science · 2014

© Laborde et al.; licensee BioMed Central Ltd. 2014https://creativecommons.org/licenses/by/4.0/This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T20:43:25.568539+00:00

DOI: 10.1186/1477-5956-12-43 · PMC4451929